Blog

Information for All Zantac (Ranitidine) Users

By April 16, 2020 May 7th, 2020 No Comments

Millions of Americans suffer from heartburn on a regular basis. For many years, Zantac (ranitidine) was prescribed and used by more than 60 million Americans dealing with heartburn at least once a month.

After research and investigations, ranitidine (brand name Zantac) tested positive for NDMA (N-nitrosodimethylamine). NDMA is a known probable human carcinogen. It’s an environmental contaminant found in water and foods that has been shown to cause cancer after exposure to high doses over an extended period of time. Studies have found the most common cancer types associated with NDMA exposure include: stomach or gastric cancer, bladder cancer, and kidney or renal cancer.

In September 2019, the FDA announced a voluntary recall of prescription ranitidine capsules distributed by Sandoz. A few months later, the FDA announced a recall of 14 forms of prescription ranitidine.

As the recalls began to make headlines, major drugstore chains began pulling ranitidine-containing medications, including Zantac, off their shelves. If you suffer from heartburn, there are many other treatment options available on the market; we urge you to speak to a health care professional.

If you or a loved one has taken Zantac and have suffered with cancer or other negative side effects, we’re here to help. Trust our experienced team of Zantac attorneys to seek justice on your behalf. Contact us today to get started with a free case evaluation.

 

Tags: , , , , , , , , , , , , , , ,